PICO Breast Reduction Clinical Study Looking at Incision Healing Complications

Not Applicable

Completed

Conditions: Delayed Healing

Interventions: Device: PICO

Registration Number: NCT01640366

Lead Sponsor: Smith & Nephew, Inc.

Brief Summary: The purpose of this study is to see if the use of a single-use negative pressure wound therapy system (NPWT) will have an effect on the reduction of post-surgical incision healing complications following breast reduction surgery and to assess the medium-term aesthetic appearance and quality of the resultant scar, compared with standard of care dressings.

Detailed Description: The aim of the present study is to assess the efficacy and cost-effectiveness of the Single-Use Negative Pressure Wound Therapy (NPWT) system (PICO) with regard to the reduction of postsurgical incision healing complications during the immediate postoperative treatment phase, and to assess the medium-term aesthetic appearance and quality of the resultant scar, in patients undergoing reduction mammoplasty, compared to standard care.

Recruitment & Eligibility

Status: COMPLETED

Sex: Female

Target Recruitment: 200

Inclusion Criteria

Female patient's ≥ 18 years old
The patient is able to understand the trial and is willing to consent to the trial
Patient has undergone an elective surgical procedure for bilateral reduction mammoplasty
Patients postsurgical incisions are of similar length

Exclusion Criteria

Pregnant or lactating females
Patients on steroids or other immune modulators known to impact healing which may affect scar appearance
Patients with tattoos in the area of the incisions
Patients with skin conditions (Cutis laxa etc.) that would result in poor healing or widened scars
Patients with a known significant history of scar problems i.e. hypertrophic scaring or keloids
Patients who in the opinion of the investigator may not complete the study for any reason
Patients with a known history of poor compliance with medical treatment
Patients who have participated in this trial previously and who were withdrawn
Patients with known allergies to product components (silicone adhesives and polyurethane films (direct contact with wound), acrylic adhesives (direct contact with skin), polyethylene fabrics and super-absorbent powders (polyacrylates) (within the dressing)
Incisions that are actively bleeding
Exposure of blood vessels, organs, bone or tendon at the base of the reference wound
Incisions > 12 inches (30cm) max linear dimension

Study & Design

Study Type: INTERVENTIONAL

Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
PICO negative pressure	PICO	Single-use Negative Pressure Wound Therapy

Primary Outcome Measures

Name	Time	Method
Number of Participants Experiencing Incision Healing Complications up to Day 21 Postoperatively	21 days postoperatively	The primary variable of whether or not the incision developed a healing complication within 21 days of surgery was defined as the presence of at least one of the following: 1. Infection (superficial or deep), 2. Dehiscence (partial, superficial or deep), 3. Delayed healing (defined as incision not closed within 7 days of the first surgical procedure). All participants received both PICO and standard care dressings simultaneously during the course of the study; randomized to either right breast for PICO and left breast for standard of care OR right breast standard of care and left breast PICO.

Secondary Outcome Measures

Name	Time	Method
Number of Participants Experiencing Postsurgical Incision Healing Complications (Dehiscence) Occurring up to Day 21 Postoperatively	21 days postoperatively	Assessment of the number of participants' incisions that experienced dehiscence (superficial, partial, or deep) occurring up to and 21 days postoperatively between incisions treated with PICO compared with standard care dressings. All participants received both PICO and standard care dressings simultaneously during the course of the study; randomized to either right breast for PICO and left breast for standard of care OR right breast standard of care and left breast PICO.
Number of Participants Experiencing Postsurgical Incision Healing Complications (Infection) Occurring up to Day 21 Postoperatively	21 days postoperatively	Assessment of the number of participants' incisions that experienced an infection (superficial or deep) occurring up to and 21 days postoperatively between incisions treated with PICO compared with standard care dressings. All participants received both PICO and standard care dressings simultaneously during the course of the study; randomized to either right breast for PICO and left breast for standard of care OR right breast standard of care and left breast PICO.
Number of Hematoma's Occurring up to and 21 Days Postoperatively	21 days postoperatively	Assessment of participants developing a hematoma up to 21 days postoperatively for incisions treated with PICO compared with standard care dressings. All participants received both PICO and standard care dressings simultaneously during the course of the study; randomized to either right breast for PICO and left breast for standard of care OR right breast standard of care and left breast PICO.
Number of Wounds Showing 100% Closure Occurring up to and 21 Days Postoperatively	21 days postoperatively	Assessment of wound appearance demonstrating 100% wound closure at 21 days postoperatively for both PICO treatment and standard of care treatment. All participants received both PICO and standard care dressings simultaneously during the course of the study; randomized to either right breast for PICO and left breast for standard of care OR right breast standard of care and left breast PICO.
Aesthetic Appearance (Cosmesis) and Scar Quality at 90 Days Postoperatively	90 days postoperatively	Assessment of the Patient and Observer Scar Assessment Scale (POSAS) and the Visual Analogue Scale (VAS) between postsurgical incisions treated with PICO compared with standard care dressings. VAS score: Assessed for color, appearance, contour, distortion, and texture. Each score ranged from 5 to 18; 5 being 'excellent' and 18 being 'poor.' Also, a global scar score was included in the total score. POSAS score: Scored in 2 parts which added to create a total score, observer score and patient score. The lowest score of 1 showed 'normal' skin and the highest score of 10 showed the 'worst imaginable' result. Observer score = 6 categories (vascularity, pigmentation, thickness, relief, pliability, and surface area) each given a score of 1-10. Patient score = 6 categories (scar pain, itching, color, stiffness, thickness, and irregularity each given a score of 1-10. All participants received both PICO and standard care dressings simultaneously during the course of the study.
Number of Participants Experiencing Postsurgical Incision Healing Complications (Delayed Healing) Occurring Within 10 Days Postoperatively	Within 10 days postoperatively	Assessment of the number of participants' incisions that experienced delayed healing within 10 days of surgery between incisions treated with PICO compared with standard care dressings. All participants received both PICO and standard care dressings simultaneously during the course of the study; randomized to either right breast for PICO and left breast for standard of care OR right breast standard of care and left breast PICO.
Number of Participants Experiencing Postsurgical Incision Healing Complications (Delayed Healing) Occurring Within 7 Days Postoperatively	Within 7 days postoperatively	Assessment of the number of participants' incisions that experienced delayed healing within 7 days of surgery between incisions treated with PICO compared with standard care dressings. All participants received both PICO and standard care dressings simultaneously during the course of the study; randomized to either right breast for PICO and left breast for standard of care OR right breast standard of care and left breast PICO.
Number of Skin, Nipple and Areola Necrosis Occurring up to and 21 Days Postoperatively	21 days postoperatively	The nipple and areola areas were not covered by the PICO or standard care dressing as part of the evaluation, they were all dressed the same with Steri-strips and dry gauze pads, which was essentially the standard care dressing regime. All participants received both PICO and standard care dressings simultaneously during the course of the study; randomized to either right breast for PICO and left breast for standard of care OR right breast standard of care and left breast PICO.

Trial Locations

Locations (6): CHU de Nantes Hôtel Dieu
🇫🇷
Nantes, France
Cleveland Clinic
🇺🇸
Cleveland, Ohio, United States
Northwestern University Feinberg School of Medicine
🇺🇸
Chicago, Illinois, United States
Academisch Ziekenhuis Maastricht (AZM)
🇳🇱
Maastricht, Netherlands
Montefiore
🇺🇸
Bronx, New York, United States
University of Cape Town
🇿🇦
Cape Town, South Africa